Press Releases
Latest
Sepul Bio Completes Enrollment in Phase 2b LUNA Clinical Trial of Ultevursen for USH2A-Associated Retinitis Pigmentosa
“Achieving the enrollment of the final participant in the Phase 2b LUNA clinical trial represents a fantastic milestone for USH2A…





























